Prospect Capital Corporation Announces Special Meeting for Stockholder Vote on Share Issuance Authorization

TL;DR

<b>Prospect Capital Corporation is seeking stockholder approval to renew its authorization to sell common stock over the next 12 months.</b>

AI Summary

PROSPECT CAPITAL CORP (PSEC-PA) filed a Proxy Statement (DEF 14A) with the SEC on March 12, 2024. Prospect Capital Corporation will hold a special meeting of stockholders on June 10, 2024, at 3:00 p.m. ET. The meeting will be held virtually at www.virtualshareholdermeeting.com/PSEC2024SM. Stockholders will vote on a proposal to renew the company's authorization to sell shares of common stock. This authorization, if approved by the Board of Directors, would be for the next 12 months. The sale of shares would be at a price to be determined.

Why It Matters

For investors and stakeholders tracking PROSPECT CAPITAL CORP, this filing contains several important signals. This vote is crucial for Prospect Capital's ability to raise capital through equity offerings, which can fund future investments and operations. Shareholder approval is required for the company to continue its strategy of issuing stock, potentially impacting dilution and future earnings per share.

Risk Assessment

Risk Level: low — PROSPECT CAPITAL CORP shows low risk based on this filing. The filing is a preliminary proxy statement (DEF 14A) and does not contain detailed financial performance data or specific transaction details, indicating it's an early stage disclosure.

Analyst Insight

Stockholders should carefully review the proxy statement to understand the implications of authorizing the sale of common stock, including potential dilution and capital raising strategies.

Key Numbers

• June 10, 2024 — Special Meeting Date (Date for the special meeting of stockholders.)
• 3:00 p.m. Eastern Time — Special Meeting Time (Time for the special meeting of stockholders.)
• 12 months — Authorization Period (Duration for which the company seeks authorization to sell common stock.)

Key Players & Entities

• PROSPECT CAPITAL CORP (company) — Registrant and filer of the proxy statement.
• June 10, 2024 (date) — Date of the Special Meeting of Stockholders.
• 20240312 (date) — Filing date of the DEF 14A.
• 10 East 40th Street, 42nd Floor New York, New York 10016 (address) — Business and mailing address of Prospect Capital Corporation.

FAQ

Risk Factors

• Authorization to Sell Common Stock [medium — regulatory]: The company is seeking stockholder approval to renew its authorization to sell shares of common stock over the next 12 months.

Industry Context

Prospect Capital Corporation operates as a business development company (BDC), investing in debt and equity of private U.S. middle-market companies.

Regulatory Implications

The filing is a Schedule 14A (DEF 14A), a proxy statement required by the SEC for soliciting proxies from shareholders for meetings.

What Investors Should Do

1. Review the proxy statement for details on the proposed share issuance authorization.
2. Understand the potential impact of share dilution and capital raising on PSEC's financial performance.
3. Vote on the proposal regarding the authorization to sell common stock.

Key Dates

• 2024-06-10: Special Meeting of Stockholders — Vote on authorization to sell common stock.

Year-Over-Year Comparison

This filing is a preliminary proxy statement (DEF 14A) and does not contain the same level of financial detail as a quarterly or annual report.

Key Financial Figures

• $1,304,721.29 — cial Meeting for a fee of approximately $1,304,721.29 plus out-of-pocket expenses. Stockhol

Filing Documents

• psec-20240312.htm (DEF 14A) — 281KB
• psec-20240312_g1.jpg (GRAPHIC) — 14KB
• psec-20240312_g2.jpg (GRAPHIC) — 12KB
• psec-20240312_g3.jpg (GRAPHIC) — 443KB
• psec-20240312_g4.jpg (GRAPHIC) — 247KB
• 0001287032-24-000084.txt (&nbsp;) — 2402KB
• psec-20240312.xsd (EX-101.SCH) — 1KB
• psec-20240312_htm.xml (XML) — 53KB

Security Ownership of Certain Beneficial Owners and Management

Security Ownership of Certain Beneficial Owners and Management As of March 12, 2024, there were no persons not identified in the following table that owned 25% or more of our outstanding voting securities, and no other person would be deemed to control us, as such term is defined in the 1940 Act. Persons identified in the following table as beneficially owning more than 25% of the our outstanding voting securities may be deemed to control us, as that term is defined in the 1940 Act. Our directors are divided into two groups - interested directors and independent directors. Interested directors are "interested persons" of the Company, as defined in the 1940 Act. The following table sets forth, as of March 12, 2024, certain ownership information with respect to our voting securities for those persons who may, insofar as is known to us, directly or indirectly own, control or hold with the power to vote, 5% or more of our outstanding voting securities and the beneficial ownership of each current director, the Company's executive officers, and the executive officers and directors as a group. 4 "Commission"), and other information obtained from such persons, if available. Such information is as of the date of the applicable filing and may no longer be accurate. Unless otherwise indicated, we believe that each person set forth in the table below has sole voting and investment power with respect to all shares of the Company's voting securities he or she beneficially owns and has the same address as the Company. Our address is 10 East 40th Street, 42nd Floor, New York, New York 10016. Common Stock Preferred Stock Name and Address of Beneficial Owner Amount and Nature of Beneficial Ownership(1) Percentage of Class(1) Amoun

View Full Filing

View this DEF 14A filing on SEC EDGAR